Unlock stock picks and a broker-level newsfeed that powers Wall Street.
OTC Markets OTCPK - Delayed Quote USD

Holista Colltech Limited (HCLHF)

Compare
0.0010
0.0000
(0.00%)
At close: March 26 at 4:00:00 PM EDT
Loading Chart for HCLHF
  • Previous Close 0.0000
  • Open 0.0010
  • Bid --
  • Ask --
  • Day's Range 0.0010 - 0.0010
  • 52 Week Range 0.0010 - 0.0010
  • Volume 13,500
  • Avg. Volume 0
  • Market Cap (intraday) 2.02M
  • Beta (5Y Monthly) 0.65
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0000
  • Earnings Date Feb 27, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Holista CollTech Limited operates as a research-driven biotech company in Australia, Malaysia, and the United States. The company operates through Supplements, Ovine Collagen, Food Ingredients, and Infection Control Solutions segments. It manufactures and wholesales dietary supplements; cosmetic grade collagen; infection control solutions; and healthy food ingredients, including low-glycemic index (GI) bread, noodles/pasta, and flatbreads, as well as low-calorie/low-GI sugar substitutes. The company also offers biogenic particles, low fat chips, and water soluble technology. Holista CollTech Limited is based in Subiaco, Australia.

www.holistaco.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: HCLHF

View More

Performance Overview: HCLHF

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .

YTD Return

HCLHF
0.00%
S&P/ASX 200 [XJO] (^AXJO)
6.02%

1-Year Return

HCLHF
0.00%
S&P/ASX 200 [XJO] (^AXJO)
1.36%

3-Year Return

HCLHF
81.82%
S&P/ASX 200 [XJO] (^AXJO)
2.05%

5-Year Return

HCLHF
81.82%
S&P/ASX 200 [XJO] (^AXJO)
51.31%

Compare To: HCLHF

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: HCLHF

View More

Valuation Measures

Annual
As of 4/4/2025
  • Market Cap

    5.73M

  • Enterprise Value

    6.70M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -1.50%

  • Return on Assets (ttm)

    5.95%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    5.6M

  • Net Income Avi to Common (ttm)

    -84.21k

  • Diluted EPS (ttm)

    -0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    21.72k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    53.31k

Research Analysis: HCLHF

View More

Company Insights: HCLHF

Research Reports: HCLHF

View More